TY - JOUR
T1 - Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790.
JO - Int J Cancer
PY - 2009/09/01
AU - Hald A
AU - Hansen RR
AU - Thomsen MW
AU - Ding M
AU - Croucher PI
AU - Gallagher O
AU - Ebetino FH
AU - Kassem M
AU - Heegaard A-M
ED -
DO - DOI: 10.1002/ijc.24436
VL - 125
IS - 5
SP - 1177
EP - 1185
Y2 - 2025/07/20
ER -